News

Ozempic maker Novo Nordisk on track for its worst day since Black Monday
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Wegovy maker Novo's profit warning triggers $70 billion share rout
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
Obesity Drugmaker Novo Nordisk Plunges as It Cuts Forecasts Again
Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its ...
Novo Nordisk Shares Plummet as Wegovy Knockoffs Weigh on Sales
The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.
NDTV Profit13m
Novo Falls By Record As Wegovy Slumps And Insider Named CEO
The appointment came shortly after Novo slashed its financial forecast, predicting this year’s sales will grow 8% to 14%, ...
Stock Movers: Novo Nordisk, Palo Alto, Union Pacific
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...
Devdiscourse1d
Novo Nordisk's Wegovy: Battling Market Challenges Amid Rising Prescriptions
The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...